[1303] Synthetic Cannabinoids - Epidemiology, Clinical ...

[1303] Synthetic Cannabinoids - Epidemiology, Clinical ...

Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The contents of the presentation may be modified, but the Psychopharmacology Institute logo must remain visible in all slides. Synthetic Cannabinoids: Epidemiology, Clinical Manifestations, and Practical Diagnostic Aspects David A. Gorelick, M.D., Ph.D., DLFAPA Professor of Psychiatry Epidemiology 2017 Global Drug Survey

Lifetime use 5.8% 77.8% Past-year use 1.1% 60% Global Drug Survey 2017. Available at https://www.globaldrugsurvey.com/wp- content/themes/globaldrugsurvey/results/GDS2017_key-findings-report_final.pdf. Accessed 02/20/2018. United Nations Office on Drugs and Crime, World Drug Report 2017. United Nations publication, Sales No. E.17.XI.6). Available at https://www.unodc.org/wdr2017/index.html. Accessed 02/20/2018.

Survey: US High School Seniors 2014-2015 Current use of synthetic cannabinoids Use on at least 3 different days 2.9% 49.7% Global Drug Survey 2017. Available at https://www.globaldrugsurvey.com/wp- content/themes/globaldrugsurvey/results/GDS2017_key-findings-report_final.pdf. Accessed 02/20/2018. United Nations Office on Drugs and Crime, World Drug Report 2017. United Nations publication, Sales No. E.17.XI.6). Available at https://www.unodc.org/wdr2017/index.html. Accessed 02/20/2018. Trends in Synthetic Cannabinoid Use

Prevalence of past-year use in 12th graders 2011-2012 2016 12 % 4 % Synthetic cannabinoid users also use plant cannabis. Clinical Manifestations

Little high-quality data on their human safety or toxicity More associated with serious medical and psychiatric problems than plant cannabis Winstock, A., Lynskey, M., Borschmann, R., & Waldron, J. (2015). Risk of emergency medical treatment following consumption of cannabis or synthetic cannabinoids in a large global sample. Journal of Psychopharmacology, 29(6), 698-703. 2017 Global Drug Survey X 5 Current/past-year synthetic cannabis users

3.2% 0.6% Sought emergency medical treatment Retrospective Case Series: Results Psychotic symptoms 77.1% 55.5% Agitation

57.1% 27.3% Psychotic disorder diagnosis 82.8% 49.8% Mood disorder diagnosis 17.1% 45.5%

Winstock, A., Lynskey, M., Borschmann, R., & Waldron, J. (2015). Risk of emergency medical treatment following consumption of cannabis or synthetic cannabinoids in a large global sample. Journal of Psychopharmacology, 29(6), 698-703. Synthetic Cannabinoid Intoxication and Withdrawal More intense Longer lasting Pharmacologic differences between synthetic cannabinoids and plant-derived cannabis Plant cannabis contains cannabidiol, which counteracts the effects of THC.

Desired subjective effects Undesired effects Anxiety Euphoria Sedation Synthetic Cannabinoi ds Effects Relaxation Increased appetite

Dizziness Conjunctival redness Tachycardia Monte, A. A., Calello, D. P., Gerona, R. R., Hamad, E., Campleman, S. L., Brent, J., ... & ACMT Toxicology Investigators Consortium. (2017). Characteristics and treatment of patients with clinical illness due to synthetic cannabinoid inhalation reported by medical toxicologists: a ToxIC Database study. Journal of Medical Toxicology, 13(2), 146-152. Mller, H. H., Kornhuber, J., & Sperling, W. (2016). The behavioral profile of spice and synthetic cannabinoids in humans. Brain research bulletin, 126, 3-7. Tait, R. J., Caldicott, D., Mountain, D., Hill, S. L., & Lenton, S. (2016). A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment. Clinical Toxicology, 54(1), 1-13. More Intense Effects + CB1 Stupor

Prolonged psychosis Increased muscle tone Muscle pain Life-Threatening Medical Complications Hypertension Nausea and vomiting

Cardiac arrhythmias Rhabdomyolysis Acute myocardial infarction Acute renal failure Monte, A. A., Calello, D. P., Gerona, R. R., Hamad, E., Campleman, S. L., Brent, J., ... & ACMT Toxicology Investigators Consortium. (2017). Characteristics and treatment of patients with clinical illness due to synthetic cannabinoid inhalation reported by medical toxicologists: a ToxIC Database study. Journal of Medical Toxicology, 13(2), 146-152. Mller, H. H., Kornhuber, J., & Sperling, W. (2016). The behavioral profile of spice and synthetic cannabinoids in humans. Brain research bulletin, 126, 3-7. Tait, R. J., Caldicott, D., Mountain, D., Hill, S. L., & Lenton, S. (2016). A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment. Clinical Toxicology, 54(1), 1-13.

Seizures Hyperventilatio n Apnea Diagnosis of Intoxication History Cannabinoid intoxication syndrome Drug sample

s Packagin g Monte, A. A., Calello, D. P., Gerona, R. R., Hamad, E., Campleman, S. L., Brent, J., ... & ACMT Toxicology Investigators Consortium. (2017). Characteristics and treatment of patients with clinical illness due to synthetic cannabinoid inhalation reported by medical toxicologists: a ToxIC Database study. Journal of Medical Toxicology, 13(2), 146-152. Tait, R. J., Caldicott, D., Mountain, D., Hill, S. L., & Lenton, S. (2016). A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment. Clinical Toxicology, 54(1), 1-13. Collateral informant s Paraphernal ia

Diagnosis is often made by exclusion. Confirmed by sophisticated and expensive assay methods Results are delayed several days False negative results possible due to novel chemical structures Monte, A. A., Calello, D. P., Gerona, R. R., Hamad, E., Campleman, S. L., Brent, J., ... & ACMT Toxicology Investigators Consortium. (2017). Characteristics and treatment of patients with clinical illness due to synthetic cannabinoid inhalation reported by medical toxicologists: a ToxIC Database study. Journal of Medical Toxicology, 13(2), 146-152. Tait, R. J., Caldicott, D., Mountain, D., Hill, S. L., & Lenton, S. (2016). A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment. Clinical Toxicology, 54(1), 1-13. Clinical Manifestations Warranting a High Index of Suspicion (1) Conjunctival redness

(2) Sudden onset of otherwise unexplained psychosis (3) Sudden onset of otherwise unexplained cognitive impairment, such as disorientation or disorganized speech Monte, A. A., Calello, D. P., Gerona, R. R., Hamad, E., Campleman, S. L., Brent, J., ... & ACMT Toxicology Investigators Consortium. (2017). Characteristics and treatment of patients with clinical illness due to synthetic cannabinoid inhalation reported by medical toxicologists: a ToxIC Database study. Journal of Medical Toxicology, 13(2), 146-152. Tait, R. J., Caldicott, D., Mountain, D., Hill, S. L., & Lenton, S. (2016). A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment. Clinical Toxicology, 54(1), 1-13. Clinical Manifestations Warranting a High Index of Suspicion (4) Sudden onset of otherwise unexplained kidney, neurological (seizure), or cardiovascular problems, such as chest pain, tachycardia, arrhythmia, or hypertension

(5) Typical signs and symptoms of cannabis intoxication when the drug test is negative for THC or cannabis Monte, A. A., Calello, D. P., Gerona, R. R., Hamad, E., Campleman, S. L., Brent, J., ... & ACMT Toxicology Investigators Consortium. (2017). Characteristics and treatment of patients with clinical illness due to synthetic cannabinoid inhalation reported by medical toxicologists: a ToxIC Database study. Journal of Medical Toxicology, 13(2), 146-152. Tait, R. J., Caldicott, D., Mountain, D., Hill, S. L., & Lenton, S. (2016). A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment. Clinical Toxicology, 54(1), 1-13. Synthetic Cannabinoid Brand Names No distinctive cannabis odor Spice and K2 Black Mamba Bliss Bombay Blue Genie

Joker Kush Kronic Zohai ~ 700 different brand names identified Image: http://mediad.publicbroadcasting.net/p/waer/files/styles/medium/public/201807/synthetic_cannabinoids_600x338.jpg Useful Resources US Drug Enforcement Administration (DEA) www.dea.gov US National Institute on Drug Abuse (NIDA) www.drugabuse.gov Clinical laboratory testing

Complete blood count Electrolytes Blood chemistry Review of systems Medical evaluation 12-lead electrocardiogram Imaging (e.g., brain imaging) Physical and neurological examination

Monte, A. A., Calello, D. P., Gerona, R. R., Hamad, E., Campleman, S. L., Brent, J., ... & ACMT Toxicology Investigators Consortium. (2017). Characteristics and treatment of patients with clinical illness due to synthetic cannabinoid inhalation reported by medical toxicologists: a ToxIC Database study. Journal of Medical Toxicology, 13(2), 146-152. Tait, R. J., Caldicott, D., Mountain, D., Hill, S. L., & Lenton, S. (2016). A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment. Clinical Toxicology, 54(1), 1-13. Key Points The diagnosis is often made by history and/or presence of typical cannabis intoxication signs, such as conjunctival redness, in the absence of a drug test positive for THC. Synthetic cannabinoids are not detected by routine drug screening tests. Diagnosis is suggested by sudden onset of unexplained psychosis; cognitive impairment; or kidney, neurological, or

cardiovascular problems. Next Presentation Management of Intoxication and Withdrawal

Recently Viewed Presentations

  • Ch­¬ng IV: Lý thuyÕt hµnh vi ng­êi s¶n xuÊt

    Ch­¬ng IV: Lý thuyÕt hµnh vi ng­êi s¶n xuÊt

    Ch­¬ng V: ThÞ tr­êng c¹nh tranh vµ ®éc quyÒn Ch­¬ng V: ThÞ tr­êng c¹nh tranh vµ ®éc quyÒn 2.1. ¶nh h­ëng ngo¹i øng tiªu cùc: * VÝ dô: xÐt ¶nh h­ëng ngo¹i øng tiªu cùc do « nhiÔm tõ viÖc...
  • DNA Analysis - Northern Highlands

    DNA Analysis - Northern Highlands

    RFLP. Length differences associated with relatively long repeating DNA strands are called restriction fragment length polymorphisms (RFLP) and form the basis for one of the first DNA typing procedures. Typically, a core sequence consists of 15 to 35 bases in...
  • SINGAPORE MATHS - Rudston Primary School

    SINGAPORE MATHS - Rudston Primary School

    Bruner's theory: Knowledge representation develops in 3 stages. Enactive - based on hands-on sensory experiences of physical objects together with the consequences that go after. Iconic - Knowledge can now be represented using models and pictures. Learners know how to...
  • DepEd PPT Template

    DepEd PPT Template

    leverage collaborative tools like Linkedin, Ning, Blogger, Wikispaces, Bebo, MSN, MySpace, Slideshare, Pinterest, Instagram and Facebook to enhance and captivate our learners. Share, contribute, adapt and invent using these collaborative tools. ... sign of a success for a teacher...is to...
  • Presentation title

    Presentation title

    (ii) is attainted of treason, or has been convicted and is under sentence, or subject to be sentenced, for any offence punishable under the law of the Commonwealth or of a State by imprisonment for one year or longer …...
  • MONITORING AND COMPLIANCE 2007 COD FISHERIES March 26,

    MONITORING AND COMPLIANCE 2007 COD FISHERIES March 26,

    Bonavista to Open Hall no activity. Bonavista North area. Springdale to Kings Point. Baie Verte to Brent's Cove. Springdale to Trition. Baie Verte to Middle Arm, Woody Point - trout River. Bonne Bay area. Little Port to Cox's Cove. 2007...
  • Ch. 19-Cattle and Cotton

    Ch. 19-Cattle and Cotton

    Cowboys and the Life on the Trail. Trail crews needed about 12 workers to manage a herd of 2,000 cattle.Wranglers were ranch hands that cared for the crew members' horses.Trail drives began in spring and ended in the fall. Cattle...
  • Productions/Operations Management

    Productions/Operations Management

    Fixed Position layout. Layout in which the product or project remains stationary, and workers, materials, and equipment are moved as needed. Fixed Position Layouts. 6-Line balancing.